Monitoring the development of AD processes in ADAD over a period of four decades showed that amyloid deposition can be detected in all persons with mutations in any gene that cause alterations in Aβ processing (APP, PSEN1, or PSEN2) even before the onset of AD symptoms but not in noncarriers of the mutation. The gene discussed is PSEN1; the disease is Alzheimer disease.